| |
| |
|
| Insider
Information: |
Azamian Bobak R. |
| Relationship: |
President/CEO and Boar... |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
26,456 |
|
|
Indirect Shares
|
830,106 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
856,562 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tarsus Pharmaceuticals, Inc. |
TARS |
President/CEO and Boar... |
2024-03-18 |
26,456 |
2024-03-18 |
830,106 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-09-01 |
4 |
AS |
$25.23 |
$147,301 |
I/I |
(5,833) |
1,221,605 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-06-21 |
4 |
AS |
$18.63 |
$149,040 |
I/I |
(8,000) |
1,023,006 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-05-10 |
4 |
AS |
$16.80 |
$151,200 |
I/I |
(9,000) |
1,051,106 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-07-12 |
4 |
AS |
$17.35 |
$156,150 |
I/I |
(9,000) |
1,014,006 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-09 |
4 |
AS |
$17.87 |
$160,830 |
I/I |
(9,000) |
1,153,106 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-12-27 |
4 |
AS |
$20.22 |
$161,760 |
I/I |
(8,000) |
830,106 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-11-01 |
4 |
AS |
$27.76 |
$162,284 |
I/I |
(5,833) |
1,209,939 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-06-14 |
4 |
AS |
$18.58 |
$167,220 |
I/I |
(9,000) |
1,031,006 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2024-03-18 |
4 |
S |
$30.60 |
$318,699 |
D/D |
(10,415) |
26,456 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-12-20 |
4 |
AS |
$19.96 |
$810,623 |
I/I |
(40,000) |
838,106 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-07-19 |
4 |
AS |
$19.28 |
$2,078,984 |
I/I |
(103,900) |
910,106 |
0 |
- |
|
61 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
